Bristol-Myers Squibb Company
As of Oct 23, 2026 close
- Market cap
- $125.91B
- P/E (TTM)
- 13.57
- Forward P/E
- 7.56
- Dividend yield
- 4.00%
- 52-week range
- $42.52$68.64
- Volume (live)
- -
- Avg. volume (3M)
- 13.44M
Bristol-Myers Squibb Company (BMY) Stock Price & Financial Analysis
Bristol-Myers Squibb Company Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $61.31 - $62.84 |
|---|---|
| 52-Week High | $68.64 |
| 52-Week Low | $42.52 |
| Open | $62.66 |
| Volume (last close) | 9.76M |
| Average Volume (3M) | 13.44M |
| Revenue (TTM) | 49.19B |
|---|---|
| Net Income (TTM) | 9.28B |
| Free Cash Flow (TTM) | 11.44B |
| EPS (TTM) | $4.54 |
| Profit Margin | 18.86% |
| Operating Margin | 26.66% |
| Return on Equity (ROE) | 41.56% |
| Debt to Equity | 1.93 |
| Annual Dividend | $2.52 |
|---|---|
| Dividend Yield | 4.00% |
| Payout Ratio | 55.52% |
| Last Dividend Ex-Date | Oct 2, 2026 |
| Market Cap | 125.91B |
|---|---|
| Shares Outstanding | 2.05B |
| P/E Ratio (TTM) | 13.57 |
| Forward P/E | 7.56 |
| Price to Sales (P/S) | 2.56 |
| Price to Book (P/B) | 5.64 |
| EV/EBITDA | 9.46 |
| 50-Day MA | $63.33 |
|---|---|
| 200-Day MA | $59.71 |
| 1-Year Change | +43.74% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Bristol-Myers Squibb Company at a Glance
As of the Oct 23, 2026 close, Bristol-Myers Squibb Company (BMY) has a market capitalization of $125.91B. The stock trades at 13.6× trailing earnings, 7.6× forward earnings and 2.6× sales. Over the trailing twelve months it earned $9.28B on revenue of $49.19B (a 18.9% profit margin) and generated $11.44B of free cash flow. Revenue grew 3.1% year over year.
As of its latest reported balance sheet, it holds $8.72B in cash and securities against $43.12B of debt, a net debt position of $34.40B.
Bristol-Myers Squibb Company pays a quarterly dividend totaling $2.52 per share a year, a 4.00% yield at the Oct 23, 2026 close, with a 56% payout ratio and 18 consecutive years of dividend increases.
The share price is up 43.7% over the past year. At $61.48 (the Oct 23, 2026 close) it sits within its 52-week range of $42.52 to $68.64, above its 200-day moving average of $59.71.
Based on 28 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $66.68, 8.5% above the Oct 23, 2026 close.
Frequently Asked Questions About Bristol-Myers Squibb Company
What is the current stock price for BMY?
As of the Oct 23, 2026 close, BMY stock trades at $61.48. The 52-week range is $42.52–$68.64, with a day range of $61.31–$62.84.
What is the P/E ratio for BMY?
As of the Oct 23, 2026 close, Bristol-Myers Squibb Company's trailing twelve-month (TTM) P/E ratio is 13.6, meaning investors pay $13.6 for every $1 of annual earnings. The forward P/E is 7.6, reflecting analyst expectations for future earnings. Bristol-Myers Squibb Company operates in the Healthcare sector.
Does BMY pay dividends?
Yes, Bristol-Myers Squibb Company pays a 4.00% annual dividend yield as of the Oct 23, 2026 close ($2.52 per share a year). The trailing twelve-month payout ratio is 55.5%. The most recent ex-dividend date was October 2, 2026.
What do analysts recommend for BMY?
Based on ratings from 28 professional analysts over the last 90 days, the consensus for BMY is Buy. The average 12-month price target is $66.68, a 8.5% upside from the Oct 23, 2026 close of $61.48.
What is the market cap of BMY?
As of the Oct 23, 2026 close, Bristol-Myers Squibb Company's market capitalization is $125.91B, classifying it as a large-cap company. Bristol-Myers Squibb Company operates in the Healthcare sector within the Drug Manufacturers - General industry.